Literature DB >> 23678840

Sexual dysfunction as a side effect of hyperprolactinemia in methadone maintenance therapy.

Aneta Spasovska Trajanovska1, Viktorija Vujovic, Liljana Ignjatova, Danijela Janicevic-Ivanovska, Aleksandar Cibisev.   

Abstract

UNLABELLED: Although endocrine abnormalities are recognized in opiate users, very little is known about the range of hormones affected, their pathophysiology and their clinical relevance. various endocrine abnormalities have been reported in these patients including, increased prolactin levels and abnormalities in sexual hormone. Path physiological mechanism postulated does explain these findings including direct action of heroin or methadone at the hypothalamic pituitary level. The aim of this study was to explore the effects of heroin and methadone maintenance treatment on the plasma prolactin levels and sexual function.
MATERIAL AND METHODS: We evaluated 20 male narcotic addicts maintained of methadone more than 3 years on oral high dose methadone 60-120 mgr/day. Patients taking neuroleptic therapy were excluded from the study because neuroleptic-included hyperprolactinemia. We also evaluated group of twenty male heroin addicts on the street heroin .The prolactin plasma levels were assayed using the chemiluminescent immunometric essay (CLIA)--high sensitive methods. The normal range of prolactin levels was 1,5-17 ng/ml (53-360 nmol/l) for men and 1,90-25,0 ng/ml for women. The sexual function was assessed using a Questionnaire: International Index of Erectile Function (IIEF) with 15 items in four levels of sexual function. The differences between two examination groups were determined by a students t test. The results show that street heroin addicts (55% of them have high level of prolactin) have significantly higher plasma prolactin levels (p = 0.006) then the group of methadone maintenance patients (only 15% of them have high prolactin level). In our study, when we compared sexual dysfunction in examination groups in some domains, we did not find statistical significant results (sexual desire p = 0.52 and overall satisfaction p = 0.087). But in domains of erectile function p = 0.011 and orgasm function p = 0.033 we got statistical significant results.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23678840     DOI: 10.5455/medarh.2013.67.48-50

Source DB:  PubMed          Journal:  Med Arch        ISSN: 0350-199X


  7 in total

1.  Rapid Transition From Methadone to Buprenorphine Utilizing a Micro-dosing Protocol in the Outpatient Veteran Affairs Setting.

Authors:  Joao P De Aquino; Christopher Fairgrieve; Sukhpreet Klaire; Gabriela Garcia-Vassallo
Journal:  J Addict Med       Date:  2020 Sep/Oct       Impact factor: 4.647

Review 2.  Sexual dysfunction in patients with alcohol and opioid dependence.

Authors:  Sandeep Grover; Surendra K Mattoo; Shreyas Pendharkar; Venkatesh Kandappan
Journal:  Indian J Psychol Med       Date:  2014-10

Review 3.  Evaluation of young men with organic erectile dysfunction.

Authors:  Dimitri Papagiannopoulos; Narenda Khare; Ajay Nehra
Journal:  Asian J Androl       Date:  2015 Jan-Feb       Impact factor: 3.285

4.  Comparing the Effects of Methadone, Buprenorphine, and Opium Tincture Maintenance Therapy on Sexual Function.

Authors:  Ali Kheradmand; Ahad Fazeli; Azadeh Mazaheri Meybodi
Journal:  Addict Health       Date:  2019-04

Review 5.  Hormones can influence drug addiction-A narrative review.

Authors:  Hamidreza Famitafreshi; Morteza Karimian
Journal:  Biomedicine (Taipei)       Date:  2021-06-01

6.  Evaluation of the protein biomarkers and the analgesic response to systemic methylene blue in patients with refractory neuropathic pain: a double-blind, controlled study.

Authors:  Adriana A Miclescu; Martin Svahn; Torsten E Gordh
Journal:  J Pain Res       Date:  2015-07-15       Impact factor: 3.133

7.  Methadone Replacement Therapy and Sexual Disorders among Opium Dependent Iranian Men: A Meta-Analysis Study.

Authors:  Masoudeh Babakhanian; Ali Akbar Haghdoost; Mahdi Afshari; Fatemeh Taghizadeh; Mahmood Moosazadeh
Journal:  Addict Health       Date:  2017-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.